Basic information Safety Supplier Related

GUANIDINOSUCCINIC ACID

Basic information Safety Supplier Related

GUANIDINOSUCCINIC ACID Basic information

Product Name:
GUANIDINOSUCCINIC ACID
Synonyms:
  • (2S)-2-(diaminomethylideneamino)butanedioic acid
  • L-ASPARTICACID,N-(AMINOIMINOMETHYL)-
  • 2-Guanidinosuccinic acid
  • (S)-GUANIDINOSUCCINIC ACID
  • guanidinosuccic acid
  • (S)-GUANIDINOSUCCINIC ACID dihydrobromide
  • GUANIDINOSUCCINIC ACID
  • N-AMIDINO-L-ASPARTIC ACID
CAS:
6133-30-8
MF:
C5H9N3O4
MW:
175.14
Product Categories:
  • amino acids
Mol File:
6133-30-8.mol
More
Less

GUANIDINOSUCCINIC ACID Chemical Properties

Boiling point:
344.5±52.0 °C(Predicted)
Density 
1.74±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMSO: 1 mg/ml; PBS (pH 7.2): 5 mg/ml
form 
A solid
pka
3.22±0.23(Predicted)
color 
White to off-white
More
Less

Safety Information

WGK Germany 
3
RTECS 
CI9098875

MSDS

More
Less

GUANIDINOSUCCINIC ACID Usage And Synthesis

Uses

Guanidinosuccinic acid is a nitrogenous metabolite.

Definition

ChEBI: An aspartic acid derivative comprising L-aspartic acid carrying an N-amidino substituent.

in vivo

Guanidinosuccinic acid, a constituent of normal urine, is elevated in the urine and serum of azotemic patients[1]. Guanidinosuccinic acid (GSA), a guanidino compound found to be greatly increased in uremia, is administered by intraperitoneal (i.p.) injection to adult albino mice and to young mice 7, 14 and 21 days old. Epileptogenic and toxic properties are assessed and Guanidinosuccinic acid brain levels following i.p. injection ae determined. In adult mice, Guanidinosuccinic acid induces long-lasting generalized clonic and clonic-tonic convulsions in a dose-dependent manner with a CD50 (and 95% confidence interval) of 363 (287-458) mg/kg (n=35), and an LD50 of 579 (445-756) mg/kg. The CD50 of Guanidinosuccinic acid corresponded with a brain concentration of 56 nmol/g tissue. Electrocorticographic recording in five adult mice revealed epileptiform discharges (spikes, spike-waves, and polyspike-waves) which appeared concomitant with the convulsions, When young mice are i.p. injected with a (for adults) subconvulsive dose of Guanidinosuccinic acid (250 mg/kg), an age-dependent decrease is noted in Guanidinosuccinic acid-induced convulsions and in the resulting brain concentration[2].

IC 50

Human Endogenous Metabolite

References

[1] Milstien S, et al. Role of intestinal microflora in the metabolism of guanidinosuccinic acid. J Bacteriol. 1973 May;114(2):641-4. DOI:10.1128/jb.114.2.641-644.1973
[2] D'Hooge R, et al. Behavioral toxicity of guanidinosuccinic acid in adult and young mice. Toxicol Lett. 1992 Dec;64-65 Spec No:773-7. DOI:10.1016/0378-4274(92)90261-h

GUANIDINOSUCCINIC ACIDSupplier

Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66099280 17798518460
Email
cfzhang@aikonchem.com
Guangzhou Isun Pharmaceutical Co., Ltd
Tel
020-39119399 18927568969
Email
isunpharm@qq.com
Shanghai Hekang Biotechnology Co., Ltd.
Tel
18939837085
Email
youchemicals@gmail.com
Alfa Chemistry
Tel
1-516-6625404
Email
support@alfa-chemistry.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com